+996.7%
MRNA vs TEVA
+81.5%
+915.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | TEVA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -0.1% | +13.2% | +13.2% |
| 7D | +20.6% | +4.7% | +15.9% | +15.8% |
| 30D | +27.1% | +5.5% | +21.6% | +21.5% |
| 3M | +353.4% | +21.6% | +331.8% | +306.5% |
| 6M | +446.3% | +18.4% | +427.9% | +396.7% |
| YTD | +776.2% | +34.1% | +742.1% | +634.6% |
| All | +996.7% | +81.5% | +915.2% | +653.2% |
Cumulative growth
Daily Returns
Daily percentage return beside TEVA.
Daily Out/Under-Performance
Portfolio return minus TEVA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TEVA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded TEVA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling